Screening reactive metabolites bioactivated by multiple enzyme pathways using a multiplexed microfluidic system.

A multiplexed, microfluidic platform to detect reactive metabolites is described, and its performance is illustrated for compounds metabolized by oxidative and bioconjugation enzymes in multi-enzyme pathways to mimic natural human drug metabolism. The device features four 8-electrode screen printed carbon arrays coated with thin films of DNA, a ruthenium-polyvinylpyridine (RuPVP) catalyst, and multiple enzyme sources including human liver microsomes (HLM), cytochrome P450 (cyt P450) 1B1 supersomes, microsomal epoxide hydrolase (EH), human S9 liver fractions (Hs9) and N-acetyltransferase (NAT). Arrays are arranged in parallel to facilitate multiple compound screening, enabling up to 32 enzyme reactions and measurements in 20-30 min. In the first step of the assay, metabolic reactions are achieved under constant flow of oxygenated reactant solutions by electrode driven natural catalytic cycles of cyt P450s and cofactor-supported bioconjugation enzymes. Reactive metabolites formed in the enzyme reactions can react with DNA. Relative DNA damage is measured in the second assay step using square wave voltammetry (SWV) with RuPVP as catalyst. Studies were done on chemicals known to require metabolic activation to induce genotoxicity, and results reproduced known features of metabolite DNA-reactivity for the test compounds. Metabolism of benzo[a]pyrene (B[a]P) by cyt P450s and epoxide hydrolase showed an enhanced relative DNA damage rate for DNA compared to cyt P450s alone. DNA damage rates for arylamines by pathways featuring both oxidative and conjugative enzymes at pH 7.4 gave better correlation with rodent genotoxicity metric TD(50). Results illustrate the broad utility of the reactive metabolite screening device.

[1]  Ian D. Wilson,et al.  Managing the challenge of chemically reactive metabolites in drug development , 2011, Nature Reviews Drug Discovery.

[2]  C. Wagner,et al.  Arylamine N-acetyltransferases: characterization of the substrate specificities and molecular interactions of environmental arylamines with human NAT1 and NAT2. , 2007, Chemical research in toxicology.

[3]  Jos H Beijnen,et al.  An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons. , 2003, Toxicology and applied pharmacology.

[4]  J. Schenkman,et al.  Electrochemiluminescent/voltammetric toxicity screening sensor using enzyme-generated DNA damage. , 2007, Biosensors & bioelectronics.

[5]  R. Zengerle,et al.  Microfluidic lab-on-a-chip platforms: requirements, characteristics and applications. , 2010, Chemical Society reviews.

[6]  G. Tarr,et al.  Purification, physicochemical, and kinetic properties of liver acetyl-CoA:arylamine N-acetyltransferase from rapid acetylator rabbits. , 1987, Molecular pharmacology.

[7]  James F Rusling,et al.  Protein film electrochemistry of microsomes genetically enriched in human cytochrome p450 monooxygenases. , 2005, Journal of the American Chemical Society.

[8]  J. Rusling,et al.  Quantitative measurement of DNA adducts using neutral hydrolysis and LC-MS. Validation of genotoxicity sensors. , 2005, Analytical chemistry.

[9]  Linlin Zhao,et al.  Evaluation of electrochemiluminescent metabolic toxicity screening arrays using a multiple compound set. , 2011, Analytical Chemistry.

[10]  J. H. Kim,et al.  Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. , 1998, Carcinogenesis.

[11]  Dhanuka P Wasalathanthri,et al.  Microfluidic electrochemical array for detection of reactive metabolites formed by cytochrome P450 enzymes. , 2011, Analytical chemistry.

[12]  J. Schenkman,et al.  Direct Electrochemistry of Cytochrome P450 Reductases in Surfactant and Polyion Films , 2007 .

[13]  S. Krishnan,et al.  Thin film voltammetry of metabolic enzymes in rat liver microsomes. , 2007, Electrochemistry communications.

[14]  G. Whitesides.  The origins and the future of microfluidics , 2006, Nature.

[15]  Romualdo Benigni,et al.  Mechanisms of chemical carcinogenicity and mutagenicity: a review with implications for predictive toxicology. , 2011, Chemical reviews.

[16]  J. Kramer,et al.  The application of discovery toxicology and pathology towards the design of safer pharmaceutical lead candidates , 2007, Nature Reviews Drug Discovery.

[17]  J. D. Stuart,et al.  Toxicity screening by electrochemical detection of DNA damage by metabolites generated in situ in ultrathin DNA-enzyme films. , 2003, Journal of the American Chemical Society.

[18]  J. Schenkman,et al.  Biochemical applications of ultrathin films of enzymes, polyions and DNA. , 2008, Chemical communications.

[19]  S. Krishnan,et al.  Genotoxicity screening for N-nitroso compounds. Electrochemical and electrochemiluminescent detection of human enzyme-generated DNA damage from N-nitrosopyrrolidine. , 2007, Chemical communications.

[20]  J. Rusling.  Sensors for toxicity of chemicals and oxidative stress based on electrochemical catalytic DNA oxidation. , 2004, Biosensors & bioelectronics.

[21]  Linlin Zhao,et al.  Differences in metabolite-mediated toxicity of tamoxifen in rodents versus humans elucidated with DNA/microsome electro-optical arrays and nanoreactors. , 2009, Chemical research in toxicology.

[22]  M. Butler,et al.  Human cytochrome P-450PA (P-450IA2), the phenacetin O-deethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Malcolm C. Pike,et al.  The TD50: a proposed general convention for the numerical description of the carcinogenic potency of chemicals in chronic-exposure animal experiments. , 1984 .

[24]  S. Krishnan,et al.  Bioelectronic delivery of electrons to cytochrome P450 enzymes. , 2011, The journal of physical chemistry. B.

[25]  Xiao-Liang Qi,et al.  Nonlocal Transport in the Quantum Spin Hall State , 2009, Science.

[26]  J. Schenkman,et al.  Electrochemical genotoxicity screening for arylamines bioactivated by N-acetyltransferase. , 2008, Analytical chemistry.

[27]  A. Nassar,et al.  Improving the decision-making process in structural modification of drug candidates: reducing toxicity. , 2004, Drug discovery today.

[28]  J. Cashman.  Some distinctions between flavin-containing and cytochrome P450 monooxygenases. , 2005, Biochemical and biophysical research communications.

[29]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[30]  J. Rusling,et al.  Simultaneous direct electrochemiluminescence and catalytic voltammetry detection of DNA in ultrathin films. , 2003, Journal of the American Chemical Society.

[31]  F. Guengerich,et al.  Cytochrome P450 activation of arylamines and heterocyclic amines. , 2005, Annual review of pharmacology and toxicology.

[32]  C J Omiecinski,et al.  Epoxide hydrolases: biochemistry and molecular biology. , 2000, Chemico-biological interactions.

[33]  F. Guengerich,et al.  Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity. , 2001, Chemical research in toxicology.

[34]  S. Krishnan,et al.  Electrochemiluminescent arrays for cytochrome P450-activated genotoxicity screening. DNA damage from benzo[a]pyrene metabolites. , 2007, Analytical chemistry.

[35]  Dhanuka P Wasalathanthri,et al.  Efficient bioelectronic actuation of the natural catalytic pathway of human metabolic cytochrome P450s. , 2011, Journal of the American Chemical Society.

[36]  Hari Singh Nalwa,et al.  Handbook of surfaces and interfaces of materials , 2001 .

[37]  J. Rusling,et al.  Detection of chemically induced DNA damage in layered films by catalytic square wave voltammetry using Ru(bpy)3(2+). , 2001, Analytical chemistry.